Literature DB >> 30633431

Chemical Epigenetics: The Impact of Chemical and Chemical Biology Techniques on Bromodomain Target Validation.

Matthias Schiedel1, Mustafa Moroglu1, David M H Ascough1, Anna E R Chamberlain1, Jos J A G Kamps1, Angelina R Sekirnik1, Stuart J Conway1.   

Abstract

Epigenetics is currently the focus of intense research interest across a broad range of disciplines due to its importance in a multitude of biological processes and disease states. Epigenetic functions result partly from modification of the nucleobases in DNA and RNA, and/or post-translational modifications of histone proteins. These modifications are dynamic, with cellular machinery identified to modulate and interpret the marks. Our focus is on bromodomains, which bind to acetylated lysine residues. Progress in the study of bromodomains, and the development of bromodomain ligands, has been rapid. These advances have been underpinned by many disciplines, but chemistry and chemical biology have undoubtedly played a significant role. Herein, we review the key chemistry and chemical biology approaches that have furthered our study of bromodomains, enabled the development of bromodomain ligands, and played a critical role in the validation of bromodomains as therapeutic targets.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  PROTACs; bromodomains; epigenetics; inhibitors; protein-protein interactions

Mesh:

Substances:

Year:  2019        PMID: 30633431     DOI: 10.1002/anie.201812164

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  8 in total

1.  Optimization of Naphthyridones into Selective TATA-Binding Protein Associated Factor 1 (TAF1) Bromodomain Inhibitors.

Authors:  Michael A Clegg; Natalie H Theodoulou; Paul Bamborough; Chun-Wa Chung; Peter D Craggs; Emmanuel H Demont; Laurie J Gordon; Gemma M Liwicki; Alex Phillipou; Nicholas C O Tomkinson; Rab K Prinjha; Philip G Humphreys
Journal:  ACS Med Chem Lett       Date:  2021-08-03       Impact factor: 4.632

2.  Photochemical synthesis of an epigenetic focused tetrahydroquinoline library.

Authors:  Adam I Green; George M Burslem
Journal:  RSC Med Chem       Date:  2021-08-25

3.  Tumor-Targeted Bivalent Protein Degradation for Application in Cancer Therapy.

Authors:  Robert B Kargbo
Journal:  ACS Med Chem Lett       Date:  2021-02-23       Impact factor: 4.345

4.  Discovery of a hidden transient state in all bromodomain families.

Authors:  Lluís Raich; Katharina Meier; Judith Günther; Clara D Christ; Frank Noé; Simon Olsson
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-26       Impact factor: 12.779

5.  Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors.

Authors:  Noah R Flynn; Michael D Ward; Mary A Schleiff; Corentine M C Laurin; Rohit Farmer; Stuart J Conway; Gunnar Boysen; S Joshua Swamidass; Grover P Miller
Journal:  Metabolites       Date:  2021-06-15

6.  Zap-Pano: a Photocaged Prodrug of the KDAC Inhibitor Panobinostat.

Authors:  Kathrin S Troelsen; Ewen D D Calder; Anna Skwarska; Deborah Sneddon; Ester M Hammond; Stuart J Conway
Journal:  ChemMedChem       Date:  2021-07-29       Impact factor: 3.540

Review 7.  Targeted Protein Degradation as a Promising Tool for Epigenetic Upregulation of Fetal Hemoglobin.

Authors:  Thijs C J Verheul; Van Tuan Trinh; Olalla Vázquez; Sjaak Philipsen
Journal:  ChemMedChem       Date:  2020-11-04       Impact factor: 3.466

8.  Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP Bromodomain.

Authors:  Michael Brand; James Clayton; Mustafa Moroglu; Matthias Schiedel; Sarah Picaud; Joseph P Bluck; Anna Skwarska; Hannah Bolland; Anthony K N Chan; Corentine M C Laurin; Amy R Scorah; Larissa See; Timothy P C Rooney; Katrina H Andrews; Oleg Fedorov; Gabriella Perell; Prakriti Kalra; Kayla B Vinh; Wilian A Cortopassi; Pascal Heitel; Kirsten E Christensen; Richard I Cooper; Robert S Paton; William C K Pomerantz; Philip C Biggin; Ester M Hammond; Panagis Filippakopoulos; Stuart J Conway
Journal:  J Med Chem       Date:  2021-07-13       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.